GURNET POINT CAPITAL
Gurnet Point Capital is a leading healthcare fund that invests in de-risked life sciences companies. Gurnet Point primarily focuses on businesses that have high growth potential in the late product development and commercialization stages of their evolution. These companies become partners not just because of their capacity to generate economic value, but also because of their potential to deliver social impact. Gurnet Point’s team of highly experienced industry executives work closely with its portfolio companies, with an active approach driving operational transformation and outsized returns. www.gurnetpointcapital.com
GURNET POINT CAPITAL
Social Links:
Industry:
Biotechnology Health Care Medical Device Pharmaceutical
Founded:
2015-01-01
Status:
Active
Contact:
617-588-4900
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Content Delivery Network Google Universal Analytics Font Awesome Apache
Similar Organizations
EpiVax
EpiVax is an immunology company developing comprehensive analytical capabilities in the field of computational immunology.
Current Advisors List
Current Employees Featured
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2022-06-23 | Radius Health | Radius Health acquired by Gurnet Point Capital | 890 M USD |
| 2018-10-11 | Corium International | Corium International acquired by Gurnet Point Capital | 504 M USD |
| 2017-04-04 | Innocoll Holdings | Innocoll Holdings acquired by Gurnet Point Capital | 209 M USD |
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-06-22 | Alladapt Immunotherapeutics | Gurnet Point Capital investment in Venture Round - Alladapt Immunotherapeutics | 119 M USD |
| 2020-12-15 | Naveris | Gurnet Point Capital investment in Series A - Naveris | N/A |
| 2020-12-09 | Tremeau Pharmaceuticals | Gurnet Point Capital investment in Private Equity Round - Tremeau Pharmaceuticals | N/A |
| 2020-02-20 | Alladapt Immunotherapeutics | Gurnet Point Capital investment in Series C - Alladapt Immunotherapeutics | 60 M USD |
| 2017-03-20 | BEFORE Brands | Gurnet Point Capital investment in Series B - BEFORE Brands | 35 M USD |
| 2016-12-07 | Crossover Health | Gurnet Point Capital investment in Venture Round - Crossover Health | 92 M USD |
| 2016-12-01 | Auregen BioTherapeutics | Gurnet Point Capital investment in Venture Round - Auregen BioTherapeutics | N/A |
| 2016-10-05 | BEFORE Brands | Gurnet Point Capital investment in Series A - BEFORE Brands | 13.1 M USD |
More informations about "Gurnet Point Capital"
Gurnet Point Capital - Crunchbase Investor Profile & Investments
Gurnet Point Capital invests in early to late-stage companies in the healthcare, biotechnology, and medical sectors, focusing on North America, particularly in California, Massachusetts, and …See details»
Gurnet Point Capital - mtec-sc.org
Gurnet Point Capital is a healthcare investment firm based in Cambridge, MA, focused on investing in scientifically de-risked life sciences companies. Founded in 2015, the firm employs …See details»
Gurnet Point Capital - Massinvestor Venture Capital and Private …
Gurnet Point Capital (GPC) is a healthcare fund founded by Ernesto Bertarelli and led by Christopher A. Viehbacher. With an initial allocation of $2 billion, GPC is investing long-term …See details»
Gurnet Point Capital | Bertarelli
Founded in 2013, Gurnet Point Capital is an investment fund that enables established healthcare and life science businesses to accelerate growth and achieve their long-term vision.See details»
Gurnet Point Capital - 2025 Investor Profile & Team - Tracxn
Jun 11, 2025 Gurnet Point Capital is a private equity firm founded in 2013. It is primarily based in Cambridge, United States. As of Jun 2025, Gurnet Point Capital has a portfolio of 14 compan …See details»
Gurnet Point Capital - Overview, News & Similar companies
Sep 25, 2023 View Gurnet Point Capital (www.gurnetpointcapital.com) location in Massachusetts, United States , revenue, industry and description. Find related and similar …See details»
Gurnet Point Capital LLC - Company Profile and News
Company profile page for Gurnet Point Capital LLC including stock price, company news, executives, board members, and contact informationSee details»
Heritage | Gurnet Point Capital
As well as having established Gurnet Point Capital, Waypoint is a major investor in a global allergy immunotherapy company, as well as one of Europe's leading, pan-European medical …See details»
Gurnet Point Capital - Private Equity Investments & Executives
See Gurnet Point Capital's 11 investments, 9 executives, and complete investor profile. Founded in 2015, Gurnet Point Capital is an investment fund that enables established healthcare and …See details»
Gurnet Point Capital LLC Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Gurnet Point Capital LLC of Cambridge, MA. Get the latest business insights from Dun & Bradstreet.See details»
Gurnet Point Capital Mergers and Acquisitions Summary | Mergr
Gurnet Point Capital is private investment group focused on the healthcare and life sciences sectors. The Firm looks to invest across all stages of product development through to …See details»
Gurnet Point Capital - Investments, Portfolio & Company Exits
Gurnet Point Capital has made 11 investments. Their most recent investment was on Oct 20, 2022, when Corium raised a new funding round. How many investments has this organization …See details»
Gurnet Point Capital - CB Insights
Sep 19, 2022 About Gurnet Point Capital Gurnet Point Capital is a private equity firm that invests in de-risked life sciences companies. It provides funds across all stages of product …See details»
GURNET POINT CAPITAL - Wiser Partners
Gurnet Point Capital invests in scientifically de-risked life science products to bring safe and effective treatments to market, positively impacting patients and generating outsized investor …See details»
Corium and Gurnet Point Capital Announce Manufacturing …
Oct 20, 2022 Corium’s core capabilities—contract development & manufacturing and neuroscience therapeutics commercialization—sharpen focus by becoming independent …See details»
News | Gurnet Point Capital
September 21, 2023 Gurnet Point Capital and Novo Holdings A/S Complete Acquisition of Paratek Pharmaceuticals, Inc. Read September 20, 2023 Radius Health Announces …See details»
Gurnet Point Capital | Investor profile | Foundersuite
Gurnet Point Capital provides capital, ideas, and commercial expertise to a select group of life science companies. The firm will invest in venture-stage companies with promising scientific …See details»
Gurnet Point Capital - Contacts, Employees, Board Members, …
Gurnet Point Capital has 12 current employee profiles, including Founder Ernesto Bertarelli. Gurnet Point Capital has 1 board member or advisor, Sophie Kornowski.See details»
Gurnet Point Capital - PrivSource
Gurnet Point Capital is a private investment firm specializing in life sciences, targeting scientifically de-risked companies to bring treatments to market and enhance patient …See details»
Gurnet Point Capital - Updates, News, Events, Signals & Triggers
Gurnet Point Capital's investment strategy appears to be centered around healthcare and life sciences, with a particular focus on biotechnology. The firm invests in companies across …See details»